Role of silymarin in cancer treatment: facts, hypotheses, and questions

T Koltai, L Fliegel - Journal of Evidence-Based Integrative …, 2022 - journals.sagepub.com
The flavonoid silymarin extracted from the seeds of Sylibum marianum is a mixture of 6
flavolignan isomers. The 3 more important isomers are silybin (or silibinin), silydianin, and …

The current landscape of the antimicrobial peptide melittin and its therapeutic potential

HQ Zhang, C Sun, N Xu, W Liu - Frontiers in Immunology, 2024 - frontiersin.org
Melittin, a main component of bee venom, is a cationic amphiphilic peptide with a linear α-
helix structure. It has been reported that melittin can exert pharmacological effects, such as …

Tumor microenvironment features and chemoresistance in pancreatic ductal adenocarcinoma: Insights into targeting physicochemical barriers and metabolism as …

TMA Carvalho, D Di Molfetta, MR Greco, T Koltai… - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor
prognosis. The lack of early diagnosis and the absence of suitable biomarkers coupled with …

Hyaluronic acid coating reduces the leakage of melittin encapsulated in liposomes and increases targeted delivery to melanoma cells

Y Li, S Ruan, Z Wang, N Feng, Y Zhang - Pharmaceutics, 2021 - mdpi.com
Melittin is a promising antitumor substance; however, it is a nonspecific cytolytic peptide,
which limits its clinical application. In this study, melittin liposomes (Mel-Lip) and hyaluronic …

A promising antitumor method: Targeting CSC with immune cells modified with CAR

B Huang, L Miao, J Liu, J Zhang, Y Li - Frontiers in Immunology, 2022 - frontiersin.org
Tumors pose a great threat to human health; as a subgroup of tumor cells, cancer stem cells
(CSCs) contribute to the genesis, development, metastasis, and recurrence of tumors …

Pirfenidone alleviates fibrosis by acting on tumour–stroma interplay in pancreatic cancer

Y Lei, J Xu, M Xiao, D Wu, H Xu, J Yang, X Mao… - British Journal of …, 2024 - nature.com
Background Pancreatic ductal adenocarcinoma (PDAC) is a malignancy with a 5-year
survival rate of 12%. The abundant mesenchyme is partly responsible for the malignancy …

[HTML][HTML] An update on gemcitabine-based chemosensitization strategies in pancreatic ductal adenocarcinoma

T Zhang, Z Gu, R Ni, X Wang, Q Jiang… - Frontiers in Bioscience …, 2023 - imrpress.com
Pancreatic cancer is the seventh leading cause of cancer-related deaths, and chemotherapy
is one of the most important treatments for pancreatic cancer. Unfortunately, pancreatic …

Bromelain mitigates liver fibrosis via targeting hepatic stellate cells in vitro and in vivo

AA Sayed, AM Soliman, M Marzouk, FF Mohammed… - Tissue and Cell, 2023 - Elsevier
Various therapeutic approaches are conducted for regression of liver fibrosis and prevent
possible further carcinogenic transformation. This study was aimed to assess the …

Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma–Derived Exosomes That Promote Macrophage M2 Polarization and Predict …

S Tan, H Tang, Z Zhang, Y Wang, H Li… - Clinical Medicine …, 2024 - journals.sagepub.com
Background: Exosomes play a role in intercellular communication and participate in the
interaction between pancreatic ductal adenocarcinoma (PDAC) cells and immune cells …

Scientific Discoveries Supporting Theories in Science: From Thinking to Practice

S Fais - International Journal of Molecular Sciences, 2022 - mdpi.com
The idea to propose this ambitious title for a Special Issue in the International Journal of
Molecular Science came, on one hand, from my personal experience in research in …